Mind & Spirit
Invest in companies transforming mental healthcare through innovative treatments and technologies. These carefully selected stocks represent leaders in psychedelic therapeutics, telehealth platforms, and neurological treatments addressing the growing global demand for mental wellness solutions.
Your Basket's Financial Footprint
Market capitalisation breakdown for the 'Mind & Spirit' basket.
- Large-cap dominance generally implies lower volatility, steadier performance and closer tracking of broad market movements.
- Best used as a core portfolio holding for diversification rather than a speculative, high-growth trade.
- Expect steady, long-term value rather than rapid, explosive gains; growth tends to be gradual.
HIMS: $11.16B
TDOC: $1.53B
CMPS: $623.62M
- Other
About This Group of Stocks
Our Expert Thinking
This collection targets the rapidly expanding mental health market by focusing on companies developing breakthrough treatments and technologies. From novel psychedelic compounds to telehealth services, these stocks represent the future of brain and emotional wellness in an increasingly destigmatized field.
What You Need to Know
This portfolio blends emerging biotechs with established medical companies creating next-generation mental health treatments. The group benefits from powerful trends including regulatory evolution, virtual care adoption, and growing acceptance of alternative therapies for psychological conditions.
Why These Stocks
We've handpicked companies with clear missions to advance mental healthcare through innovation. This selection includes both pioneering startups developing novel compounds and established firms with strong market positions, all poised to address large, underserved patient populations.
Why You'll Want to Watch These Stocks
Breaking Mental Health Barriers
These companies are pioneering treatments once considered impossible, creating therapies that could help millions with treatment-resistant conditions like severe depression and PTSD.
Regulatory Winds Shifting
A fundamental change in how regulators view novel therapeutics is quickly unlocking massive new markets, especially for previously restricted compounds showing promise for mental health.
The Next Healthcare Revolution
Mental health is becoming as important as physical health, with spending expected to surge as stigma fades and innovative digital platforms make treatment more accessible than ever before.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Cybersecurity Investment Surge After Breach Explained
The U.S. Treasury has cancelled its contracts with Booz Allen Hamilton following a major data breach, signaling a new era of accountability for government contractors. This move is expected to drive significant investment into specialized cybersecurity and data protection firms as agencies seek to secure their sensitive information.
Meta Subscriptions: What's Next for Social Media?
Meta is introducing premium subscriptions for its apps, signaling a major shift away from relying solely on ad revenue. This theme focuses on companies poised to benefit as the social media industry increasingly adopts paid, feature-based subscription models.
Auto Supply Chain Stability Explained
Ford and GM are negotiating a rescue package for a key parts supplier, highlighting the critical need for stability in the automotive supply chain. This creates an investment opportunity in financially robust suppliers that are essential to vehicle production.